Analysts: Crawford & Co (CRDb.N)
CRDb.N on New York Stock Exchange
7.60USD
1 Aug 2013
7.60USD
1 Aug 2013
Price Change (% chg)
$-0.26 (-3.31%)
$-0.26 (-3.31%)
Prev Close
$7.86
$7.86
Open
$7.90
$7.90
Day's High
$7.90
$7.90
Day's Low
$7.50
$7.50
Volume
15,540
15,540
Avg. Vol
19,929
19,929
52-wk High
$8.59
$8.59
52-wk Low
$3.48
$3.48
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.24 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 1 | 1 | 1 |
| (2) OUTPERFORM | 0 | 0 | 0 | 0 |
| (3) HOLD | 2 | 2 | 2 | 2 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.33 | 2.33 | 2.33 | 2.33 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 3 | 276.67 | 281.50 | 273.99 | 284.50 |
| Quarter Ending Dec-13 | 3 | 268.91 | 278.79 | 255.74 | 276.80 |
| Year Ending Dec-13 | 3 | 1,134.76 | 1,164.00 | 1,112.41 | 1,143.03 |
| Year Ending Dec-14 | 3 | 1,145.04 | 1,177.00 | 1,126.90 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 3 | 0.24 | 0.25 | 0.21 | 0.21 |
| Quarter Ending Dec-13 | 3 | 0.22 | 0.24 | 0.21 | 0.16 |
| Year Ending Dec-13 | 3 | 0.84 | 0.88 | 0.80 | 0.68 |
| Year Ending Dec-14 | 3 | 0.87 | 0.90 | 0.85 | -- |
| LT Growth Rate (%) | 2 | 9.00 | 10.00 | 8.00 | 12.50 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 280.57 | 286.28 | 5.71 | 2.03 |
| Quarter Ending Dec-12 | 297.84 | 312.98 | 15.14 | 5.08 |
| Quarter Ending Sep-12 | 274.67 | 302.14 | 27.47 | 10.00 |
| Quarter Ending Jun-12 | 279.56 | 293.85 | 14.28 | 5.11 |
| Quarter Ending Mar-12 | 286.27 | 267.75 | 18.52 | 6.47 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.24 | 0.17 | 0.07 | 29.17 |
| Quarter Ending Dec-12 | 0.25 | 0.42 | 0.17 | 68.00 |
| Quarter Ending Sep-12 | 0.17 | 0.33 | 0.16 | 97.96 |
| Quarter Ending Jun-12 | 0.15 | 0.20 | 0.05 | 36.33 |
| Quarter Ending Mar-12 | 0.14 | 0.12 | 0.02 | 14.29 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 276.67 | 276.67 | 276.67 | 276.67 | 284.50 |
| Quarter Ending Dec-13 | 268.91 | 268.91 | 268.91 | 268.91 | 276.80 |
| Year Ending Dec-13 | 1,134.76 | 1,134.76 | 1,108.16 | 1,108.16 | 1,143.03 |
| Year Ending Dec-14 | 1,145.04 | 1,145.04 | 1,118.06 | 1,118.06 | -- |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.24 | 0.24 | 0.24 | 0.24 | 0.21 |
| Quarter Ending Dec-13 | 0.22 | 0.22 | 0.22 | 0.22 | 0.16 |
| Quarter Ending Dec-13 | 0.84 | 0.84 | 0.84 | 0.84 | 0.68 |
| Quarter Ending Dec-14 | 0.87 | 0.87 | 0.87 | 0.87 | -- |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 1 | 0 |
| Year Ending Dec-14 | 0 | 0 | 1 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates